Seoul Pharma Co., Ltd (KOSDAQ:018680)

South Korea · Delayed Price · Currency is KRW

2,085.00

-190.00 (-8.35%)

At close: Jun 19, 2026

-39.12% (1Y)

Market Cap	24.31B -40.3%
Revenue (ttm)	51.33B -3.2%
Net Income	725.89M -22.9%
EPS	62.26 -22.9%
Shares Out	11.66M
PE Ratio	33.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,772
Open	2,315.00
Previous Close	2,275.00
Day's Range	2,005.00 - 2,315.00
52-Week Range	2,005.00 - 3,545.00
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Seoul Pharma

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and m... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 172

Stock Exchange KOSDAQ

Ticker Symbol 018680

Full Company Profile

Financial Performance

In 2025, Seoul Pharma's revenue was 52.15 billion, a decrease of -2.67% compared to the previous year's 53.58 billion. Earnings were 753.64 million, a decrease of -55.63%.

Financial Statements